Proteases and their Receptors as Mediators of Inflammation-Associated Colon Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|21|2983-2992

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.21, 2015-06, pp. : 2983-2992

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [ Inflammatory Bowel Disease and Inflammation-Associated Colon Cancer:Partners in Crime Guest Editor: Silvio Danese ]

By  

Current Drug Targets, Vol. 9, Iss. 5, 2008-05 ,pp. : 360-360

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines, Inflammation and Colon Cancer

By  

Current Cancer Drug Targets, Vol. 11, Iss. 4, 2011-05 ,pp. : 451-464

Bentham Science Publishers

Access to resources Recommend Favorite

Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases

By  

Current Medicinal Chemistry, Vol. 18, Iss. 15, 2011-05 ,pp. : 2257-2262

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammation-Associated Changes in Bone Homeostasis

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 3, 2012-06 ,pp. : 188-195

Bentham Science Publishers

Access to resources Recommend Favorite

Dual Role of S100A8 and S100A9 in Inflammation-Associated Cancer

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 8, Iss. 4, 2009-12 ,pp. : 329-336

Bentham Science Publishers

Access to resources Recommend Favorite